Matches in Wikidata for { <http://www.wikidata.org/entity/Q59244980> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q59244980 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q59244980 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59244980 description "scientific article published on 28 September 2018" @default.
- Q59244980 description "wetenschappelijk artikel" @default.
- Q59244980 description "наукова стаття, опублікована у вересні 2018" @default.
- Q59244980 name "The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials" @default.
- Q59244980 name "The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials" @default.
- Q59244980 type Item @default.
- Q59244980 label "The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials" @default.
- Q59244980 label "The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials" @default.
- Q59244980 prefLabel "The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials" @default.
- Q59244980 prefLabel "The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials" @default.
- Q59244980 P1433 Q59244980-820CE102-CB63-4062-A0B5-C45639AF38D8 @default.
- Q59244980 P1476 Q59244980-B3890808-1119-4AAC-B456-7FCE9555524C @default.
- Q59244980 P2093 Q59244980-444E913F-FED3-4422-B140-0315AAF2BE9D @default.
- Q59244980 P2093 Q59244980-48AD8A34-9071-4315-AFAE-01A95CD0DBB1 @default.
- Q59244980 P2093 Q59244980-B827C285-8B91-4A5D-B7EA-19E525FE9328 @default.
- Q59244980 P2093 Q59244980-C51A139D-60EB-4339-9E17-81DEE4E38F35 @default.
- Q59244980 P2093 Q59244980-DD5CFC90-8720-4620-A156-89B9021179BF @default.
- Q59244980 P2093 Q59244980-EDC6C9E1-4C90-49D4-B13F-8E1EC83D4961 @default.
- Q59244980 P2093 Q59244980-F2A11569-53E6-4100-AA64-9F6207F1F7A6 @default.
- Q59244980 P2860 Q59244980-5FFD2543-B3F6-43DA-80E9-54CD31B83DEA @default.
- Q59244980 P2860 Q59244980-7B9BD0B4-AE8D-4A92-8226-FDD0C6D1C284 @default.
- Q59244980 P2860 Q59244980-86FF2381-61D9-4677-85CC-38951ABA9261 @default.
- Q59244980 P2860 Q59244980-8B4517E6-8745-493C-B60D-3CEDDECF10EB @default.
- Q59244980 P2860 Q59244980-9A4BB6DE-1419-4896-B563-90CAD56B600C @default.
- Q59244980 P2860 Q59244980-AF9E4ADE-7476-4A24-9497-355FD72EE626 @default.
- Q59244980 P2860 Q59244980-B2EDFFAC-0E1E-443F-995D-A07693C5AFD4 @default.
- Q59244980 P2860 Q59244980-BADD67A7-A615-4883-B25B-84FE870BD3F2 @default.
- Q59244980 P2860 Q59244980-BF313DF4-26FB-4F8F-A820-1879390FEBD5 @default.
- Q59244980 P2860 Q59244980-C1D40319-5F40-46E7-84F3-AD70F90479E8 @default.
- Q59244980 P2860 Q59244980-C9EC0C73-E2EA-4573-A1C9-9E2F830F65AE @default.
- Q59244980 P2860 Q59244980-E204B08D-7954-4E12-BEA7-AB3D38DB0C99 @default.
- Q59244980 P2888 Q59244980-9013617B-86FF-41EE-BD42-ECABD94DCAE2 @default.
- Q59244980 P304 Q59244980-88949708-DA8E-4E24-9569-8C914E167E94 @default.
- Q59244980 P31 Q59244980-9C34513B-1183-4D30-AF8B-0025B1D3CF3C @default.
- Q59244980 P356 Q59244980-EDC68D1C-5573-4F62-B34B-0B425732C35A @default.
- Q59244980 P433 Q59244980-59C55AF3-17B5-4AD9-A95A-B734527D0291 @default.
- Q59244980 P478 Q59244980-F6F01A10-A2D7-47D5-B94B-9A73922BB750 @default.
- Q59244980 P50 Q59244980-4481E5E3-809D-4199-8689-0EF00A8C5C01 @default.
- Q59244980 P577 Q59244980-9AFADCFC-F6C9-411B-AB1A-D906A48D4A3F @default.
- Q59244980 P698 Q59244980-2C478689-0DC7-4875-B0B0-3144067F894A @default.
- Q59244980 P921 Q59244980-3DADF0BF-755F-40D0-ACBC-F0B55F681A68 @default.
- Q59244980 P921 Q59244980-75615303-4934-4D24-9A6C-7E3FD2C930D1 @default.
- Q59244980 P356 S41375-018-0272-0 @default.
- Q59244980 P698 30267010 @default.
- Q59244980 P1433 Q6534498 @default.
- Q59244980 P1476 "The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials" @default.
- Q59244980 P2093 "Carsten Helleberg" @default.
- Q59244980 P2093 "Henrik Gregersen" @default.
- Q59244980 P2093 "Niels Abildgaard" @default.
- Q59244980 P2093 "Niels Frost Andersen" @default.
- Q59244980 P2093 "Peter Gimsing" @default.
- Q59244980 P2093 "Tobias W Klausen" @default.
- Q59244980 P2093 "Ulf Christian Frølund" @default.
- Q59244980 P2860 Q28067187 @default.
- Q59244980 P2860 Q33430928 @default.
- Q59244980 P2860 Q34815786 @default.
- Q59244980 P2860 Q38444697 @default.
- Q59244980 P2860 Q38714291 @default.
- Q59244980 P2860 Q38852886 @default.
- Q59244980 P2860 Q39065872 @default.
- Q59244980 P2860 Q40070763 @default.
- Q59244980 P2860 Q42878211 @default.
- Q59244980 P2860 Q44918517 @default.
- Q59244980 P2860 Q46427111 @default.
- Q59244980 P2860 Q50578063 @default.
- Q59244980 P2888 s41375-018-0272-0 @default.
- Q59244980 P304 "546-549" @default.
- Q59244980 P31 Q13442814 @default.
- Q59244980 P356 "10.1038/S41375-018-0272-0" @default.
- Q59244980 P433 "2" @default.
- Q59244980 P478 "33" @default.
- Q59244980 P50 Q39679727 @default.
- Q59244980 P577 "2018-09-28T00:00:00Z" @default.
- Q59244980 P698 "30267010" @default.
- Q59244980 P921 Q103824 @default.
- Q59244980 P921 Q42824827 @default.